-
1دورية أكاديمية
المؤلفون: Paciaroni M., Caso V., Agnelli G., Mosconi M.G., Giustozzi M., Seiffge D.J., Engelter S.T., Lyrer P., Polymeris A.A., Kriemler L., Zietz A., Putaala J., Strbian D., Tomppo L., Michel P., Strambo D., Salerno A., Remillard S., Buehrer M., Bavaud O., Vanacker P., Zuurbier S., Yperzeele L., Loos C.M.J., Cappellari M., Emiliani A., Zedde M., Abdul-Rahim A., Dawson J., Cronshaw R., Schirinzi E., Del Sette M., Stretz C., Kala N., Reznik M., Schomer A., Grory B.M., Jayaraman M., Mctaggart R., Yaghi S., Furie K.L., Masotti L., Grifoni E., Toni D., Risitano A., Falcou A., Petraglia L., Lotti E.M., Padroni M., Pavolucci L., Lochner P., Silvestrelli G., Ciccone A., Alberti A., Venti M., Traballi L., Urbini C., Kargiotis O., Rocco A., Diomedi M., Marcheselli S., Caliandro P., Zauli A., Reale G., Antonenko K., Rota E., Tassinari T., Saia V., Palmerini F., Aridon P., Arnao V., Monaco S., Cottone S., Baldi A., D'Amore C., Ageno W., Pegoraro S., Ntaios G., Sagris D., Giannopoulos S., Kosmidou M., Ntais E., Romoli M., Pantoni L., Rosa S., Bertora P., Chiti A., Canavero I., Saggese C.E., Plocco M., Giorli E., Palaiodimou L., Bakola E., Tsivgoulis G., Bandini F., Gasparro A., Terruso V., Mannino M., Pezzini A., Ornello R., Sacco S., Popovic N., Scoditti U., Genovese A., Denti L., Flomin Y., Mancuso M., Ferrari E., Caselli M.C., Ulivi L., Giannini N., De Marchis G.M.
المصدر: Stroke ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135281933&doi=10.1161%2fSTROKEAHA.121.038239&partnerID=40&md5=66fd1cd7a8ce00381ac49cf67b0fc3beTest
مصطلحات موضوعية: anticoagulant agent, antithrombocytic agent, blood clotting factor 10a inhibitor, dabigatran, hemoglobin, low molecular weight heparin, nonvitamin K antagonist oral anticoagulant, unclassified drug, warfarin, acute ischemic stroke, adult, age, alcohol abuse, anticoagulant therapy, Article, atherosclerosis small vessel disease cardiac pathology other causes and dissection classification, atrial fibrillation, bleeding, blood transfusion, blood vessel occlusion, brain hemorrhage, cardioembolic stroke, CHA2DS2-VASc score, cohort analysis, computer assisted tomography, controlled study, disease classification, drug substitution, drug withdrawal, embolism
-
2دورية أكاديمية
المؤلفون: Archontakis-Barakakis P., Li W., Kalaitzoglou D., Tzelves L., Manolopoulos A., Giannopoulos S., Giamouzis G., Giannakoulas G., Batsidis A., Palaiodimos L., Ntaios G., Lip G.Y.H., Kokkinidis D.G.
المصدر: British Journal of Clinical Pharmacology ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135785939&doi=10.1111%2fbcp.15464&partnerID=40&md5=618c2e64b4d8a26faf2be5a10cf52498Test
مصطلحات موضوعية: anticoagulant agent, antivitamin K, apixaban, dabigatran, rivaroxaban, dipyrone, vitamin K group, aged, Article, atrial fibrillation, brain hemorrhage, drug efficacy, drug megadose, drug safety, drug use, female, human, ischemic stroke, low drug dose, male, medical history, meta analysis, publication bias, risk assessment, risk factor, stroke patient, systematic review, thromboembolism, brain ischemia, cerebrovascular accident
-
3دورية أكاديمية
المؤلفون: Paciaroni M., Agnelli G., Caso V., Silvestrelli G., Seiffge D.J., Engelter S., De Marchis G.M., Polymeris A., Zedde M.L., Yaghi S., Michel P., Eskandari A., Antonenko K., Sohn S.-I., Cappellari M., Tassinari T., Tassi R., Masotti L., Katsanos A.H., Giannopoulos S., Acciarresi M., Alberti A., Venti M., Mosconi M.G., Vedovati M.C., Pierini P., Giustozzi M., Lotti E.M., Ntaios G., Kargiotis O., Monaco S., Lochner P., Bandini F., Liantinioti C., Palaiodimou L., Abdul-Rahim A.H., Lees K., Mancuso M., Pantoni L., Rosa S., Bertora P., Galliazzo S., Ageno W., Toso E., Angelini F., Chiti A., Orlandi G., Denti L., Flomin Y., Marcheselli S., Mumoli N., Rimoldi A., Verrengia E., Schirinzi E., Del Sette M., Papamichalis P., Komnos A., Popovic N., Zarkov M., Rocco A., Diomedi M., Giorli E., Ciccone A., Grory B.C.M., Furie K.L., Bonetti B., Saia V., Guideri F., Acampa M., Martini G., Grifoni E., Padroni M., Karagkiozi E., Perlepe K., Makaritsis K., Mannino M., MacCarrone M., Ulivi L., Giannini N., Ferrari E., Pezzini A., Doronin B., Volodina V., Baldi A., D'Amore C., Deleu D., Corea F., Putaala J., Santalucia P., Nardi K., Risitano A., Toni D., Tsivgoulis G.
المصدر: Stroke ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070182732&doi=10.1161%2fSTROKEAHA.119.025350&partnerID=40&md5=9086a48343386a19ae013e70007e0a78Test
مصطلحات موضوعية: anticoagulant agent, apixaban, creatinine, dabigatran, edoxaban, rivaroxaban, age, aged, anemia, anticoagulant therapy, artery occlusion, Article, atherosclerosis, atrial fibrillation, brain ischemia, cardioembolic stroke, case control study, cerebrovascular accident, CHA2DS2-VASc score, comparative study, congestive heart failure, controlled study, creatinine clearance, diabetes mellitus, falling, female, gastrointestinal symptom, heart atrium enlargement, human, hyperlipidemia
-
4دورية أكاديمية
المؤلفون: Tsivgoulis G., Wilson D., Katsanos A.H., Sargento-Freitas J., Marques-Matos C., Azevedo E., Adachi T., von der Brelie C., Aizawa Y., Abe H., Tomita H., Okumura K., Hagii J., Seiffge D.J., Lioutas V.-A., Traenka C., Varelas P., Basir G., Krogias C., Purrucker J.C., Sharma V.K., Rizos T., Mikulik R., Sobowale O.A., Barlinn K., Sallinen H., Goyal N., Yeh S.-J., Karapanayiotides T., Wu T.Y., Vadikolias K., Ferrigno M., Hadjigeorgiou G., Houben R., Giannopoulos S., Schreuder F.H.B.M., Chang J.J., Perry L.A., Mehdorn M., Marto J.-P., Pinho J., Tanaka J., Boulanger M., Salman R.A.-S., Jäger H.R., Shakeshaft C., Yakushiji Y., Choi P.M.C., Staals J., Cordonnier C., Jeng J.-S., Veltkamp R., Dowlatshahi D., Engelter S.T., Parry-Jones A.R., Meretoja A., Mitsias P.D., Alexandrov A.V., Ambler G., Werring D.J.
المصدر: Annals of Neurology ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055512078&doi=10.1002%2fana.25342&partnerID=40&md5=41b3cd2226ca17234c9d9e5fdf8cd058Test
مصطلحات موضوعية: anticoagulant agent, apixaban, dabigatran, fresh frozen plasma, idarucizumab, rivaroxaban, vitamin K group, aged, Article, brain hemorrhage, cerebrovascular accident, clinical outcome, drug use, female, follow up, functional status, Glasgow coma scale, hematoma, hospital mortality, human, international normalized ratio, major clinical study, male, mortality, National Institutes of Health Stroke Scale, neuroimaging, priority journal, adult, antagonists and inhibitors, chemically induced
-
5دورية أكاديمية
المؤلفون: Tsivgoulis G., Lioutas V.-A., Varelas P., Katsanos A.H., Goyal N., Mikulik R., Barlinn K., Krogias C., Sharma V.K., Vadikolias K., Dardiotis E., Karapanayiotides T., Pappa A., Zompola C., Triantafyllou S., Kargiotis O., Ioakeimidis M., Giannopoulos S., Kerro A., Tsantes A., Mehta C., Jones M., Schroeder C., Norton C., Bonakis A., Chang J., Alexandrov A.W., Mitsias P., Alexandrov A.V.
المصدر: Neurology ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030621358&doi=10.1212%2fWNL.0000000000004362&partnerID=40&md5=3f26894697c787d10a30199d7d822a15Test
مصطلحات موضوعية: apixaban, dabigatran, hydroxymethylglutaryl coenzyme A reductase inhibitor, rivaroxaban, warfarin, anticoagulant agent, vitamin K group, adult, aged, anticoagulant therapy, Article, atrial fibrillation, brain blood volume, brain hemorrhage, cerebrovascular accident, CHA2DS2-VASc score, chronic kidney failure, clinical outcome, controlled clinical trial, controlled study, cross-sectional study, disease severity, female, hospital admission, human, major clinical study, male, meta analysis, multicenter study, National Institutes of Health Stroke Scale